The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kostyuk G.P.

Alekseev Psychiatric Clinical Hospital No. 1

Golubev S.A.

Gannushkin Psychiatric Clinical Hospital No. 4;
Mental Health Research Centre

Masyakin A.V.

Ministry of Health of the Moscow region

Shumakova E.A.

Gannushkin Psychiatric Clinical Hospital No. 4

Allenov A.M.

City policlinic N 210;
Sechenov First Moscow State Medical University

Mamatenko Yu.A.

Metronom Ltd

Comorbidity of somatic diseases in psychiatric patients

Authors:

Kostyuk G.P., Golubev S.A., Masyakin A.V., Shumakova E.A., Allenov A.M., Mamatenko Yu.A.

More about the authors

Read: 6210 times


To cite this article:

Kostyuk GP, Golubev SA, Masyakin AV, Shumakova EA, Allenov AM, Mamatenko YuA. Comorbidity of somatic diseases in psychiatric patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(1):77‑83. (In Russ.)
https://doi.org/10.17116/jnevro202112101177

Recommended articles:
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
Mental health protection in the primary health care: medico-social effe­ctiveness. Russian Journal of Preventive Medi­cine. 2024;(10):29-35
«Selfish brain» theory: modern concept and practical use. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):66-73
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151

References:

  1. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212–217.  https://doi.org/10.1192/bjp.177.3.212
  2. Mortensen P, Juel K. Mortality and causes of death in schizophrenic patients in Denmark. Acta Psychiatr Scand. 1990;81(4):372–377.  https://doi.org/10.1111/j.1600-0447.1990.tb05466.x
  3. Anderson C, Connelly J, Johnstone EC, Owens DG. Disabilities and circumstances of schizophrenic patients--a follow-up study. Cause of death. Br J Psychiatry Suppl. 1991;(13):30–3, 44–6. 
  4. Newman S, Bland R. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry. 1991;36(4):239–245.  https://doi.org/10.1177/070674379103600401
  5. Brook OH. Mortality in the long-state population of Dutch mental hospitals. Acta Psychiatr Scand. 1985;71(6):626–635.  https://doi.org/10.1111/j.1600-0447.1985.tb02558.x
  6. Herrman H, Baldwin JA, Christie D. A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychol Med. 1983;13(3):581–593.  https://doi.org/10.1017/s0033291700048005
  7. Jones DR, Macias C, Barreira PJ, et al. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv. 2004;55(11):1250–1257. https://doi.org/10.1176/appi.ps.55.11.1250
  8. Samele C, Lawton-Smith S, Warner L, Mariathasan J. Patient choice in psychiatry. Br J Psychiatry. 2007;191:1–2.  https://doi.org/10.1192/bjp.bp.106.031799
  9. Dixon L, Weiden P, Delahanty J, et al. Prevalence and Correlates of Diabetes in National Schizophrenia Samples. Schizophr Bull. 2000;26(4):903–912.  https://doi.org/10.1093/oxfordjournals.schbul.a033504
  10. Meyer J, Nasrallah H, McEvoy J, et al. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res. 2005;80(1):9–18.  https://doi.org/10.1016/j.schres.2005.07.015
  11. Osborn D, Marston L, Nazareth I, et al. Relative risks of cardiovascular disease in people prescribed olanzapine, risperidone and quetiapine. Schizophr Res. 2017;183:116–123.  https://doi.org/10.1016/j.schres.2016.11.009
  12. Hippisley-Cox J, Vinogradova Y, Coupland C, Parker C. Risk of Malignancy in Patients With Schizophrenia or Bipolar Disorder. Arch Gen Psychiatry. 2007;64(12):1368–1376. https://doi.org/10.1001/archpsyc.64.12.1368
  13. Mallinger J, Lamberti J. Clozapine-Should race affect prescribing guidelines? Schizophr Res. 2006;83(1):107–108.  https://doi.org/10.1016/j.schres.2006.01.017
  14. Omotoso BA, Abdel-Rahman EM, Scully K, et al. Major Depression: A Risk Factor for Long-Term Major Cardiovascular Events (MACE) and Mortality in Acute Kidney Injury. Am J Kidney Dis. 2016;67(5):A82.  https://doi.org/10.1053/j.ajkd.2016.03.261
  15. Federal’naya sluzhba gosudarstvennoi statistiki. Zabolevaemost’ naseleniya sotsial’no-znachimymi boleznyami (dannye Minzdrava Rossii, raschet Rosstata). Accessed Jan 18, 2021. (In Russ.). https://rosstat.gov.ru/folder/13721
  16. Kostyuk GP, Shmukler AB, Golubev SA, et al. Epidemiological aspects of diagnosis of schizophrenia in Moscow. Sotsial’naya i klinicheskaya psikhiatriya. 2017;27(3):5–9. (In Russ.).
  17. Sokolov RE. The role of gender in the formation of manifest schizophrenic psychoses in adolescents. Neurosci Behav Physi. 2012;42:855–861.  https://doi.org/10.1007/s11055-012-9649-0

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.